Home Evaluation of genus-specific and species-specific real-time PCR assays for the identification of Brucella spp.
Article
Licensed
Unlicensed Requires Authentication

Evaluation of genus-specific and species-specific real-time PCR assays for the identification of Brucella spp.

Published/Copyright: October 31, 2007
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 11

Abstract

Background: The identification of Brucella isolates using conventional microbiological techniques is time-consuming and hazardous. We therefore assessed the performance of real-time PCR assays for the identification of members of the genus Brucella to the genus and species level.

Methods: We evaluated an in-house developed assay and various previously published real-time PCR assays targeting bcsp31, per, IS711, alkB/IS711 and BMEI1162/IS711 using 248 Brucella strains representing the biotypes of all species and a large panel of clinically relevant, phylogenetically related and serologically cross-reacting bacteria.

Results: No misidentification was observed. However, several biotypes of Brucella abortus and Brucella suis were not detected with some of the published assays. The limit of detection varied widely among the assays (16–1600 fg) demonstrating that some assays should not be applied to clinical samples but may help to identify colony material.

Conclusions: In summary, most of the assays revealed low detection limits and proved to be highly selective for the detection of the genus Brucella and the species that are most relevant for humans. Assays targeting the bcsp31 gene can be recommended to screen for Brucella. Species-specific assays should be consecutively applied confirming the primary diagnosis by a second gene target.

Clin Chem Lab Med 2007;45:1464–70.


Corresponding author: Sascha Al Dahouk, MD, Department of Internal Medicine III, RWTH Aachen University, Pauwelsstraße 30, 52074 Aachen, Germany Phone: +49-241-80-80867, Fax: +49-241-80-82052,

Received: 2007-4-24
Accepted: 2007-6-29
Published Online: 2007-10-31
Published in Print: 2007-11-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Current state and future directions of neurochemical biomarkers for Alzheimer's disease
  2. Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations
  3. Analysis of ferritin genes in Parkinson disease
  4. Multimers and adiponectin gene 276G>T polymorphism in the Japanese population residing in rural areas
  5. Evaluation of genus-specific and species-specific real-time PCR assays for the identification of Brucella spp.
  6. A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease
  7. Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with myocardial infarction in Tunisian patients
  8. How useful are housekeeping genes? Variable expression in melanoma metastases
  9. Combined androgen blockade therapy can convert RT-PCR detection of prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) transcripts from positive to negative in the peripheral blood of patients with clinically localized prostate cancer and increase biochemical failure-free survival after curative therapy
  10. Isobutyryl-CoA dehydrogenase deficiency with a novel ACAD8 gene mutation detected by tandem mass spectrometry newborn screening
  11. Circulating levels of osteoprotegerin and receptor activator of NF-κB ligand in patients with chronic renal failure
  12. Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor
  13. Impact of rosiglitazone on the expression of β3-AR in the stable cell lines expressed β3-AR gene
  14. Biochemical and hormonal composition, cytological examination of thyroid cyst fluid, and comparison according to gender and color of cyst fluid
  15. Redefining functional sensitivity of thyroglobulin assay on Immulite platform: implications in thyroid cancer management
  16. Developmental changes in the L-arginine/nitric oxide pathway from infancy to adulthood: plasma asymmetric dimethylarginine levels decrease with age
  17. Umbilical cord blood serum procalcitonin by Time-Resolved Amplified Cryptate Emission (TRACE) technology: reference values of a potential marker of vertically transmitted neonatal sepsis
  18. Point-of-care creatinine testing in children at risk for sudden deterioration of renal function
  19. Utility of PFA-100® closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro
  20. Reliability assessment of glucose measurement by HemoCue analyser in a neonatal intensive care unit
  21. Validation study of Axis-Shield carbohydrate-deficient transferrin (CDT) on ARCHITECT® chemistry analyzer
  22. High free serum acrolein levels in bacterial infection and other disease states associated with oxidative stress: a potential biomarker?
  23. Increased serum S100B protein in chronic schizophrenic patients in Korea
  24. Addendum to the recent report of EC4 on the accreditation of medical laboratories in the European Union
  25. Reply to the letter written by Haeckel
  26. The systemic inflammatory response syndrome C-reactive protein and transthyretin conundrum
  27. Transthyretin, nutrition, and inflammation: response to Dr. Bernstein
  28. Erratum
Downloaded on 25.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.305/html
Scroll to top button